Overreaching vs Overtraining: What the Evidence Shows

Every serious lifter eventually pushes too hard for too long, and for a while, that is exactly what is supposed to happen. A brutal training block that leaves you flat for a few days is not a failure, it is often the whole point. The uncomfortable part is knowing where that line sits before you cross it, and the research says most of the tools lifters reach for to find that line do not actually work.

Overreaching and overtraining sit on one spectrum, from a planned dip in performance that supercompensates into a personal best, through to a state that can take months to unwind. Sports science has spent three decades trying to build an early-warning system for the far end of that spectrum. The findings are more humbling than most training content admits, and they say something useful about what is actually worth watching between sessions.

Three Words, One Spectrum

The 2013 joint consensus statement from the European College of Sport Science and the American College of Sports Medicine is still the reference point for how this is defined¹. Functional overreaching (FOR) is a short-term performance drop from accumulated training stress that resolves within days to roughly two weeks, and typically leaves the athlete performing better than before, the mechanism behind a deliberate overreach-and-taper block. Non-functional overreaching (NFOR) is the same fatigue picture without the rebound, recovery stretches out for weeks to months, and the athlete's numbers stay down. Overtraining syndrome (OTS) is the far end: prolonged maladaptation across the neuroendocrine, immune, and psychological systems that can take months to resolve and often comes with mood disturbance well beyond training-specific fatigue.

The consensus statement is candid about a problem that shapes everything downstream: distinguishing NFOR from OTS "is very difficult" and depends on clinical judgement and ruling out other causes, not a test result¹. There is no blood marker, questionnaire score, or heart rate number that draws a clean line between the three states. That single admission is worth sitting with before looking at any specific monitoring tool, because it reframes the goal from "detect overtraining" to "track the trend and act early."

What the Resistance-Training Evidence Actually Shows

Most overreaching research was built on endurance athletes, and lifting does not always behave the same way. A 2020 systematic review in Sports Medicine set out to fix that, searching for every study that experimentally induced overreaching or overtraining using resistance exercise protocols². It found 22 usable studies: eight showed a performance decrement with proper follow-up testing, four showed a decrement without follow-up, and ten showed no decrement at all despite the training overload.

The review's central conclusion is blunt: "no marker other than a sustained decrease in performance has been established as a reliable indicator of overtraining in resistance exercise"². Not a hormone panel, not a mood questionnaire, not resting heart rate. The authors also flagged that the resistance-training literature suffers from inconsistent diagnostic criteria and a near-total lack of standardised follow-up testing, meaning much of what gets called "overtraining" in older studies was never confirmed against a recovery timeline at all. High-intensity, monotonous training loads correlated with maladaptation risk, but the mechanism linking dose to outcome remains poorly mapped for lifting specifically².

The Hormones Do Not Behave the Way You Would Expect

Testosterone-to-cortisol ratio is the classic overtraining marker taught in exercise physiology courses, built largely on endurance data. Resistance training does not follow the same script. Fry and Kraemer's foundational review of neuroendocrine responses to resistance overtraining found that high-volume protocols echo the aerobic overtraining pattern, but high-intensity protocols produce a distinctly different hormonal signature³.

A controlled study from the same research group makes the point concretely. Eleven weight-trained men trained daily at 100% of 1RM for two weeks, a deliberately extreme intensity overload, against a low-volume control group⁴. The overtrained group's one-rep max fell and their exercise-induced testosterone rose slightly, from 26.5 to 29.1 nmol/L, while cortisol dropped, from 656.1 to 503.1 nmol/L. The testosterone-to-cortisol ratio actually improved. Growth hormone and peptide F tracked the same in both groups throughout. The authors concluded this hormonal profile "is distinctly different from what has been previously reported for other types of overtraining"⁴, which means a lifter checking their T:C ratio for reassurance after a brutal high-intensity block could see a favourable number while their strength is already declining.

A broader systematic review of 38 studies across FOR, NFOR, and OTS found the same pattern of unreliability at rest: basal hormone levels were mostly normal across all three states compared to healthy athletes⁵. The one signal that did separate overtrained athletes from controls was blunted growth hormone and ACTH response during a stimulation test, a lab procedure no one is running between training sessions⁵.

Heart Rate Variability Is Not the Shortcut It Is Marketed As

Wearable-driven heart rate variability (HRV) has become the default recovery signal for a generation of athletes, and the evidence for what it actually tells you is more qualified than the marketing suggests. A widely cited review of training-load monitoring tools concluded plainly that "very few of these markers have strong scientific evidence supporting their use, and there is yet to be a single, definitive marker described in the literature," spanning hormonal, cardiovascular, questionnaire, and performance-based approaches alike⁶.

A meta-analysis of 24 studies on autonomic heart rate regulation and training status found the specific failure mode that matters here: increases in post-exercise HRV and heart rate recovery show up during positive adaptation, but the same increases also show up during overreaching⁷. In other words, a rising HRV trend does not reliably tell you whether you are supercompensating or sliding into non-functional overreaching, the two states can look identical on a chest strap. Heart rate acceleration showed more promise as a specific fatigue signal, but the authors were careful to frame it as one input among several rather than a standalone verdict⁷.

The One Signal That Keeps Showing Up

Strip away the hormone panels and the HRV trend lines, and the resistance-training literature converges on something almost anticlimactic: sustained output. A 2021 cross-sectional survey of 605 competitive resistance-trained athletes asked what maladaptation actually feels like in practice⁸. Seventy-one percent reported an unexplained performance decrease at some point, most often lasting one week to one month. General fatigue was the single most common self-reported symptom, and the more severe, longer-lasting cases (over four months) were disproportionately linked to training to muscle failure. Notably, 92.5% of maladaptation episodes involved additional non-training stressors, life stress compounding training stress rather than training stress acting alone⁸.

A controlled overreaching study reinforces why performance itself, not a proxy for it, remains the most trustworthy signal. Researchers ran a two-week overreaching cycle in resistance-trained individuals and tracked creatine kinase, cortisol, and testosterone alongside strength and power output⁹. The biochemical markers moved, but it was the direct performance measures that most clearly tracked the overreaching state and its resolution during the taper that followed⁹. The consistent thread across this literature is that indirect markers are noisy proxies at best, while a sustained drop in what the muscle can actually produce, tracked across sessions rather than judged from any single workout, is the signal that has held up.

What This Means in Practice

None of this argues against monitoring altogether, it argues for monitoring the right thing and being honest about what a single data point can and cannot tell you. A recovery framework proposed in a 2018 international consensus statement puts it well: managing training-recovery balance is an ongoing process of load, monitoring, and adjustment, not a single test that clears or flags an athlete¹⁰. One flat session is meaningless. A trend, held across a training block against your own baseline rather than a population average, is where the signal actually lives.

This is the interpretive gap the ZELOS wearable is built to close for lifters who cannot run a lab stimulation test between sets. Because the sensor sits on the working muscle rather than the wrist, it can surface set-to-set and session-to-session output directly, the same category of signal the resistance-training literature keeps pointing back to, expressed as a contextual comparison against your own recent history rather than a raw score that means little in isolation. Watching that trend across a training block, alongside how you feel and how your loads are moving, is a more grounded way to catch a non-functional overreach early than waiting on a hormone panel or a wearable's HRV score to move first.

Key Takeaways

• Functional overreaching, non-functional overreaching, and overtraining syndrome sit on one spectrum, distinguished mainly by how long recovery takes, not by any single test.

• A 2020 systematic review of resistance-training overreaching found no marker other than a sustained performance decrement has been established as reliable, across 22 experimentally induced overreaching studies.

• Resistance-training overtraining does not reliably follow the classic testosterone:cortisol overtraining pattern seen in endurance sport, a two-week daily 100% 1RM protocol actually improved the ratio while strength fell.

• Rising heart rate variability shows up in both positive adaptation and overreaching, making a single HRV reading a poor standalone signal despite its popularity.

• Sustained output, tracked against your own trend rather than judged from one session, remains the most consistently supported early signal in the literature.

References

1. Meeusen, R., Duclos, M., Foster, C., Fry, A., Gleeson, M., Nieman, D., Raglin, J., Rietjens, G., Steinacker, J., & Urhausen, A. (2013). Prevention, diagnosis, and treatment of the overtraining syndrome: Joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. Medicine & Science in Sports & Exercise, 45(1), 186 to 205.

2. Grandou, C., Wallace, L., Impellizzeri, F. M., Allen, N. G., & Coutts, A. J. (2020). Overtraining in resistance exercise: An exploratory systematic review and methodological appraisal of the literature. Sports Medicine, 50(4), 815 to 828.

3. Fry, A. C., & Kraemer, W. J. (1997). Resistance exercise overtraining and overreaching. Neuroendocrine responses. Sports Medicine, 23(2), 106 to 129.

4. Fry, A. C., Kraemer, W. J., & Ramsey, L. T. (1998). Pituitary-adrenal-gonadal responses to high-intensity resistance exercise overtraining. Journal of Applied Physiology, 85(6), 2352 to 2359.

5. Cadegiani, F. A., & Kater, C. E. (2017). Hormonal aspects of overtraining syndrome: A systematic review. BMC Sports Science, Medicine and Rehabilitation, 9, 14.

6. Halson, S. L. (2014). Monitoring training load to understand fatigue in athletes. Sports Medicine, 44(Suppl 2), S139 to S147.

7. Bellenger, C. R., Fuller, J. T., Thomson, R. L., Davison, K., Robertson, E. Y., & Buckley, J. D. (2016). Monitoring athletic training status through autonomic heart rate regulation: A systematic review and meta-analysis. Sports Medicine, 46(10), 1461 to 1486.

8. Grandou, C., Wallace, L., Coutts, A. J., Bell, L., & Impellizzeri, F. M. (2021). Symptoms of overtraining in resistance exercise: International cross-sectional survey. International Journal of Sports Physiology and Performance, 16(1), 90 to 100.

9. Wilson, J. M., Grant, S. C., Lee, S. R., Masad, I. S., Park, Y. M., Henning, P. C., Stephens, B. R., Loenneke, J. P., Anderson, J. C., & Wilson, S. M. (2014). Beta-hydroxy-beta-methylbutyrate free acid reduces markers of exercise-induced muscle damage and improves recovery in resistance-trained men. British Journal of Nutrition, 110(3), 538 to 544.

10. Kellmann, M., Bertollo, M., Bosquet, L., Brink, M., Coutts, A. J., Duffield, R., Erlacher, D., Halson, S. L., Hecksteden, A., Heidari, J., Kallus, K. W., Meeusen, R., Mujika, I., Robazza, C., Skorski, S., Venter, R., & Beckmann, J. (2018). Recovery and performance in sport: Consensus statement. International Journal of Sports Physiology and Performance, 13(2), 240 to 245.